JP2025506473A5 - - Google Patents
Info
- Publication number
- JP2025506473A5 JP2025506473A5 JP2024547305A JP2024547305A JP2025506473A5 JP 2025506473 A5 JP2025506473 A5 JP 2025506473A5 JP 2024547305 A JP2024547305 A JP 2024547305A JP 2024547305 A JP2024547305 A JP 2024547305A JP 2025506473 A5 JP2025506473 A5 JP 2025506473A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- cycloalkyl
- group
- substituted
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2022075604 | 2022-02-09 | ||
| CNPCT/CN2022/075604 | 2022-02-09 | ||
| PCT/CN2023/074936 WO2023151574A1 (en) | 2022-02-09 | 2023-02-08 | Heterocyclic glp-1 agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025506473A JP2025506473A (ja) | 2025-03-11 |
| JP2025506473A5 true JP2025506473A5 (cg-RX-API-DMAC10.html) | 2026-02-17 |
Family
ID=87563618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547305A Pending JP2025506473A (ja) | 2022-02-09 | 2023-02-08 | ヘテロ環glp-1アゴニスト |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250177362A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4476216A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025506473A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119343343A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023151574A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021219019A1 (en) | 2020-04-29 | 2021-11-04 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| PE20231181A1 (es) | 2020-08-06 | 2023-08-11 | Gasherbrum Bio Inc | Agonistas del glp-1 heterociclicos |
| SI4408840T1 (sl) | 2021-09-27 | 2025-12-31 | Terns Pharmaceuticals, Inc. | Benzimidazolne karboksilne kisline kot agonisti GLP-1R |
| US12024507B2 (en) | 2021-10-25 | 2024-07-02 | Terns Pharmaceuticals, Inc. | Compounds as GLP-1R agonists |
| JP2025506474A (ja) * | 2022-02-09 | 2025-03-11 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環glp-1アゴニスト |
| AU2023224854A1 (en) | 2022-02-23 | 2024-10-03 | Terns Pharmaceuticals, Inc. | Compounds as glp-1r agonists |
| PE20252787A1 (es) | 2023-04-07 | 2025-12-22 | Terns Pharmaceuticals Inc | Combinacion que comprende un agonista de thr-beta y un agonista de glp-1r para su uso en el tratamiento de un trastorno hepatico o una enfermedad cardiometabolica |
| EP4777197A2 (en) | 2023-09-14 | 2026-07-22 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| WO2025109387A1 (en) | 2023-11-24 | 2025-05-30 | Ascletis Pharma (China) Co., Limited | Glp-1r agonist and therapeutic method thereof |
| WO2025158275A1 (en) | 2024-01-24 | 2025-07-31 | Pfizer Inc. | Combination therapy using glucose-dependent insulinotropic polypeptide receptor antagonist compounds and glp-1 receptor agonist compounds |
| WO2025222000A1 (en) * | 2024-04-19 | 2025-10-23 | Eli Lilly And Company | Substituted 1,1'-biphenyl compounds as glucagon receptor agonists |
| TW202606664A (zh) * | 2024-04-19 | 2026-02-16 | 美商美國禮來大藥廠 | 升糖素受體促效劑及其作為療法之用途 |
| WO2026078617A1 (en) * | 2024-10-11 | 2026-04-16 | Pfizer Inc. | Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190060A1 (ar) * | 2016-09-26 | 2019-03-26 | Chugai Pharmaceutical Co Ltd | مشتق بيرازولو بيريدين له تأثير مساعد لمستقبل glp-1 |
| WO2018109607A1 (en) * | 2016-12-16 | 2018-06-21 | Pfizer Inc. | Glp-1 receptor agonists and uses thereof |
| CA3045644C (en) * | 2018-06-13 | 2024-01-16 | Pfizer Inc. | Glp-1 receptor agonists and uses thereof |
| PE20231181A1 (es) * | 2020-08-06 | 2023-08-11 | Gasherbrum Bio Inc | Agonistas del glp-1 heterociclicos |
| JP2025506474A (ja) * | 2022-02-09 | 2025-03-11 | ガシャーブラム・バイオ・インコーポレイテッド | ヘテロ環glp-1アゴニスト |
-
2023
- 2023-02-08 EP EP23752354.3A patent/EP4476216A4/en active Pending
- 2023-02-08 JP JP2024547305A patent/JP2025506473A/ja active Pending
- 2023-02-08 WO PCT/CN2023/074936 patent/WO2023151574A1/en not_active Ceased
- 2023-02-08 CN CN202380031897.1A patent/CN119343343A/zh active Pending
- 2023-02-08 US US18/837,152 patent/US20250177362A1/en active Pending